AIMS/HYPOTHESIS: The relationships between smoking and glycaemic variables have not been well explored. We compared HbA1c, fasting plasma glucose (FPG) and 2 h plasma glucose (2H-PG) in current, ex- and never-smokers. METHODS: This meta-analysis used individual data from 16,886 men and 18,539 women without known diabetes in 12 DETECT-2 consortium studies and in the French Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR) and Telecom studies. Means of three glycaemic variables in current, ex- and never-smokers were modelled by linear regression, with study as a random factor. The I (2) statistic was used to evaluate heterogeneity among studies. RESULTS: HbA1c was 0.10% (95% CI 0.08, 0.12) (1.1 mmol/mol [0.9, 1.3]) higher in current smokers and 0.03% (0.01, 0.05) (0.3 mmol/mol [0.1, 0.5]) higher in ex-smokers, compared with never-smokers. For FPG, there was no significant difference between current and never-smokers (-0.004 mmol/l [-0.03, 0.02]) but FPG was higher in ex-smokers (0.12 mmol/l [0.09, 0.14]). In comparison with never-smokers, 2H-PG was lower (-0.44 mmol/l [-0.52, -0.37]) in current smokers, with no difference for ex-smokers (0.02 mmol/l [-0.06, 0.09]). There was a large and unexplained heterogeneity among studies, with I (2) always above 50%; I (2) was little changed after stratification by sex and adjustment for age and BMI. In this study population, current smokers had a prevalence of diabetes that was 1.30% higher as screened by HbA1c and 0.52% lower as screened by 2H-PG, in comparison with never-smokers. CONCLUSION/ INTERPRETATION: Across this heterogeneous group of studies, current smokers had a higher HbA1c and lower 2H-PG than never-smokers. This will affect the chances of smokers being diagnosed with diabetes.
AIMS/HYPOTHESIS: The relationships between smoking and glycaemic variables have not been well explored. We compared HbA1c, fasting plasma glucose (FPG) and 2 h plasma glucose (2H-PG) in current, ex- and never-smokers. METHODS: This meta-analysis used individual data from 16,886 men and 18,539 women without known diabetes in 12 DETECT-2 consortium studies and in the French Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR) and Telecom studies. Means of three glycaemic variables in current, ex- and never-smokers were modelled by linear regression, with study as a random factor. The I (2) statistic was used to evaluate heterogeneity among studies. RESULTS: HbA1c was 0.10% (95% CI 0.08, 0.12) (1.1 mmol/mol [0.9, 1.3]) higher in current smokers and 0.03% (0.01, 0.05) (0.3 mmol/mol [0.1, 0.5]) higher in ex-smokers, compared with never-smokers. For FPG, there was no significant difference between current and never-smokers (-0.004 mmol/l [-0.03, 0.02]) but FPG was higher in ex-smokers (0.12 mmol/l [0.09, 0.14]). In comparison with never-smokers, 2H-PG was lower (-0.44 mmol/l [-0.52, -0.37]) in current smokers, with no difference for ex-smokers (0.02 mmol/l [-0.06, 0.09]). There was a large and unexplained heterogeneity among studies, with I (2) always above 50%; I (2) was little changed after stratification by sex and adjustment for age and BMI. In this study population, current smokers had a prevalence of diabetes that was 1.30% higher as screened by HbA1c and 0.52% lower as screened by 2H-PG, in comparison with never-smokers. CONCLUSION/ INTERPRETATION: Across this heterogeneous group of studies, current smokers had a higher HbA1c and lower 2H-PG than never-smokers. This will affect the chances of smokers being diagnosed with diabetes.
Authors: L A Sargeant; K T Khaw; S Bingham; N E Day; R N Luben; S Oakes; A Welch; N J Wareham Journal: Int J Epidemiol Date: 2001-06 Impact factor: 7.196
Authors: S Soulimane; D Simon; J E Shaw; P Z Zimmet; S Vol; D Vistisen; D J Magliano; K Borch-Johnsen; B Balkau Journal: Diabet Med Date: 2011-11 Impact factor: 4.359
Authors: Robert Beaglehole; Ruth Bonita; Richard Horton; Cary Adams; George Alleyne; Perviz Asaria; Vanessa Baugh; Henk Bekedam; Nils Billo; Sally Casswell; Michele Cecchini; Ruth Colagiuri; Stephen Colagiuri; Tea Collins; Shah Ebrahim; Michael Engelgau; Gauden Galea; Thomas Gaziano; Robert Geneau; Andy Haines; James Hospedales; Prabhat Jha; Ann Keeling; Stephen Leeder; Paul Lincoln; Martin McKee; Judith Mackay; Roger Magnusson; Rob Moodie; Modi Mwatsama; Sania Nishtar; Bo Norrving; David Patterson; Peter Piot; Johanna Ralston; Manju Rani; K Srinath Reddy; Franco Sassi; Nick Sheron; David Stuckler; Il Suh; Julie Torode; Cherian Varghese; Judith Watt Journal: Lancet Date: 2011-04-05 Impact factor: 79.321
Authors: D L Christensen; H Friis; D L Mwaniki; B Kilonzo; I Tetens; M K Boit; B Omondi; L Kaduka; K Borch-Johnsen Journal: Diabetes Res Clin Pract Date: 2009-04-09 Impact factor: 5.602
Authors: David W Dunstan; Paul Z Zimmet; Timothy A Welborn; Adrian J Cameron; Jonathan Shaw; Maximilian de Courten; Damien Jolley; Daniel J McCarty Journal: Diabetes Res Clin Pract Date: 2002-08 Impact factor: 5.602
Authors: Adam Hulman; Rebecca K Simmons; Dorte Vistisen; Adam G Tabák; Jacqueline M Dekker; Marjan Alssema; Femke Rutters; Anitra D M Koopman; Thomas P J Solomon; John P Kirwan; Torben Hansen; Anna Jonsson; Anette Prior Gjesing; Hans Eiberg; Arne Astrup; Oluf Pedersen; Thorkild I A Sørensen; Daniel R Witte; Kristine Færch Journal: Endocrine Date: 2016-10-03 Impact factor: 3.633
Authors: Adam Hulman; Dorte Vistisen; Charlotte Glümer; Michael Bergman; Daniel R Witte; Kristine Færch Journal: Diabetologia Date: 2017-10-06 Impact factor: 10.122
Authors: Rachel J Keith; Mahmoud Al Rifai; Christopher Carruba; Natasha De Jarnett; John W McEvoy; Aruni Bhatnagar; Michael J Blaha; Andrew P Defilippis Journal: PLoS One Date: 2016-06-20 Impact factor: 3.240